MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-31-2025
Stryker Corporation Retained Earnings 2011-2026 | SYK
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Stryker Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18.5 B | 16.8 B | 14.8 B | 13.5 B | 12.5 B | 11.7 B | 10.8 B | 8.99 B | 8.84 B | 7.79 B | 7.56 B | 7.62 B | 7.33 B | 6.48 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 18.5 B | 6.48 B | 10.9 B |
Quarterly Retained Earnings Stryker Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20 B | 19.4 B | 18.9 B | 18.3 B | 17.8 B | 17.3 B | 15.9 B | 15.5 B | 15.1 B | 14.8 B | 14.5 B | - | 13.5 B | 13.5 B | 13.1 B | 12.9 B | 12.5 B | 12.5 B | 12.5 B | 12.5 B | 12.5 B | 11.7 B | 11.7 B | 11.7 B | 11.7 B | 10.8 B | 10.8 B | 10.8 B | 10.8 B | 8.99 B | 8.99 B | 8.99 B | 8.99 B | 8.84 B | 8.84 B | 8.84 B | 8.84 B | 7.79 B | 7.79 B | 7.79 B | 7.79 B | 7.56 B | 7.56 B | 7.56 B | 7.56 B | 7.62 B | 7.62 B | 7.62 B | 7.62 B | 7.33 B | 7.33 B | 7.33 B | 7.33 B | 6.48 B | 6.48 B | 6.48 B | 6.48 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 20 B | 6.48 B | 10.9 B |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
828 M | - | - | $ 17.2 B |  USA |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-157 M | $ 9.57 | 0.1 % | $ 687 M |  Israel |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
-1.28 B | $ 22.65 | -0.15 % | $ 3.24 B | USA |
 |
AxoGen
AXGN
|
-291 M | $ 33.63 | 0.78 % | $ 1.49 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Apyx Medical Corporation
APYX
|
-54.4 M | $ 3.5 | 1.16 % | $ 121 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 3.66 | -3.56 % | $ 136 M |  France |
 |
Electromed
ELMD
|
21.2 M | $ 28.9 | -0.41 % | $ 244 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
7.42 B | $ 323.76 | 1.47 % | $ 9.13 B | USA |
 |
BioSig Technologies
BSGM
|
-255 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
2.67 B | $ 97.6 | -0.79 % | $ 144 B | USA |
 |
CONMED Corporation
CNMD
|
560 M | $ 43.07 | -2.56 % | $ 1.33 B | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
2.41 B | $ 54.12 | 3.12 % | $ 8.06 K | USA |
 |
Abbott Laboratories
ABT
|
47.3 B | $ 125.84 | -0.27 % | $ 219 B | USA |
 |
InMode Ltd.
INMD
|
875 M | $ 14.47 | 1.47 % | $ 1.15 B | Israel |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
IRIDEX Corporation
IRIX
|
-79 M | $ 1.16 | -2.94 % | $ 18.7 M | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | USA |
|
LENSAR
LNSR
|
-143 M | $ 11.6 | -0.6 % | $ 134 M | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
Orthofix Medical
OFIX
|
-276 M | $ 15.77 | -2.65 % | $ 601 M |  Curacao |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
-122 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
Align Technology
ALGN
|
2.48 B | $ 172.23 | 0.97 % | $ 12.9 B | USA |
 |
Accuray Incorporated
ARAY
|
-519 M | $ 0.89 | -0.47 % | $ 91.5 M | USA |
 |
IRadimed Corporation
IRMD
|
56.8 M | $ 98.81 | -1.19 % | $ 1.25 B | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
-191 M | $ 15.06 | -1.63 % | $ 407 M | USA |
 |
FONAR Corporation
FONR
|
-33.6 M | $ 18.56 | 0.02 % | $ 122 M | USA |
 |
Sintx Technologies
SINT
|
-271 M | $ 3.78 | -1.32 % | $ 14.1 M | USA |
 |
Sensus Healthcare
SRTS
|
13.4 M | $ 4.82 | 8.8 % | $ 78.6 M | USA |
 |
Globus Medical
GMED
|
1.15 B | $ 94.0 | -0.66 % | $ 12.8 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
940 M | $ 13.69 | -1.23 % | $ 1.05 B | USA |